World Investment Advisors Increases Holdings in Intuitive Surgical, Inc. $ISRG

World Investment Advisors raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 99.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,596 shares of the medical equipment provider’s stock after purchasing an additional 796 shares during the period. World Investment Advisors’ holdings in Intuitive Surgical were worth $867,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in ISRG. Norway Savings Bank grew its holdings in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares during the period. IronOak Wealth LLC. bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $1,099,000. Trust Co. of Oklahoma purchased a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $363,000. Neville Rodie & Shaw Inc. grew its stake in shares of Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after buying an additional 1,110 shares during the last quarter. Finally, Bessemer Group Inc. increased its position in Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after buying an additional 371,806 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on ISRG. Evercore ISI boosted their target price on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. BTIG Research lifted their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the transaction, the director directly owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 96,011 shares of company stock worth $50,309,042. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 0.8%

Shares of NASDAQ ISRG opened at $534.28 on Friday. The firm’s 50-day moving average price is $464.32 and its 200-day moving average price is $498.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market cap of $191.53 billion, a PE ratio of 70.67, a PEG ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.84 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.